Skip to content

Clinical trials

Gastroesophageal Reflux trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroesophageal Reflux Country / region: Australia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20052
20068
20072
20082
20091
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Wyeth is now a wholly owned subsidiary of Pfizer3
Bayside Health2
Eisai Inc.2
GlaxoSmithKline2
Takeda2
Austin Health1
Cogentus Pharmaceuticals1
Janssen-Cilag Pty Ltd1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroesophageal Reflux19
Heartburn2
Acute Coronary Syndrome1
Bronchiectasis1
Cerebrovascular Disorders1
Colonic Diseases1
Colonic Polyps1
Coronary Artery Disease1
Coronary Thrombosis1
Cystic Fibrosis1

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.